Results 141 to 150 of about 9,498 (160)

Sofosbuvir plus ribavirin for treatment of hepatitis C virus in patients co-infected with HIV (PHOTON-2): a multicentre, open-label, non-randomised, phase 3 study

Lancet, The, 2015
jean-michel Molina, Chloe Orkin, Mark Nelson   +2 more
exaly  

Ledipasvir and Sofosbuvir for Untreated HCV Genotype 1 Infection

New England Journal of Medicine, 2014
Nezam Afdhal, Stefan Zeuzem, Massimo Puoti   +2 more
exaly  

Sofosbuvir and Velpatasvir for HCV Genotype 2 and 3 Infection

New England Journal of Medicine, 2015
Graham R Foster, Nezam Afdhal, Eric Lawitz   +2 more
exaly  

Sofosbuvir and Ribavirin in HCV Genotypes 2 and 3

New England Journal of Medicine, 2014
Stefan Zeuzem, Alessandra Mangia, Robert Flisiak   +2 more
exaly  

Sofosbuvir

Reactions Weekly, 2015
openaire   +2 more sources

Daclatasvir plus Sofosbuvir for Previously Treated or Untreated Chronic HCV Infection

New England Journal of Medicine, 2014
Mark S Sulkowski, K Rajender Reddy, Eric Lawitz   +2 more
exaly  

Daclatasvir plus Sofosbuvir for HCV in Patients Coinfected with HIV-1

New England Journal of Medicine, 2015
Mark S Sulkowski, Douglas T Dieterich
exaly  

Ledipasvir and Sofosbuvir for 8 or 12 Weeks for Chronic HCV without Cirrhosis

New England Journal of Medicine, 2014
Kris V Kowdley, K Rajender Reddy, Eric Lawitz   +2 more
exaly  

Sofosbuvir and Velpatasvir for HCV in Patients with Decompensated Cirrhosis

New England Journal of Medicine, 2015
Jonathan M Fenkel, K Rajender Reddy, Eric Lawitz   +2 more
exaly  

Sofosbuvir for Hepatitis C Genotype 2 or 3 in Patients without Treatment Options

New England Journal of Medicine, 2013
Mark S Sulkowski, Eric Lawitz, Keyur Patel   +2 more
exaly